Placebo Asenapine

DRUG2 trials

Sponsors

Organon and Co, Forest Laboratories

Conditions

Schizophrenia

Phase 3

A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

CompletedNCT01617187

Organon and CoSchizophrenia

Start: 2012-12-04End: 2014-09-09Updated: 2024-06-18

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

CompletedNCT01617200

Forest LaboratoriesSchizophrenia

Start: 2012-12-31End: 2015-03-31Updated: 2015-05-27